AI x Bio research should not be treated as one switch, says the post
lemire · x · 2026-07-22
The post argues that treating all AI x Bio research as one capability that AI companies can simply switch on or off is a mistake.
- It says much of the relevant biodefense work is not actually dual-use.
- It argues labs can do better than a binary policy, for example by using tiered access.
- The core point is that bio-related AI governance should be more granular than a single yes/no switch.
Related event: Experts Call for Nuanced AI Biosecurity Regulations(2 posts)→
More from Safety
- PHP2Shell exploits confirmed in the wild, attackers may use agentic AI for post-exploitation — AravSrinivas · 2026-10-27
- php2shell exploit benchmark: only 2 of 5 frontier models can port the bug — xeophon · 2026-10-27
- Interactive 32-slide AI security & privacy lecture for lawyers, now public — chrisrohlf · 2026-10-27
- Two CVSS 9.9 Wasmtime flaws allow sandbox escape, one ARM64-only since 2020 — basedjensen · 2026-10-27
- Free prepare.aiendgame.com site guides users through locking down accounts amid AI cyberstorm — harris_edouard · 2026-10-27
- Cisco routers trust eMudhra CAs whose private keys were numbers under 256 — murat_kocaoglu_ · 2026-10-27